UNIVERSITY OF MICHIGAN HEALTH SYSTEM

All Five Longitude Health Member Systems Join as Design Partners for Cell and Gene Therapy Utility

- Longitude Health announced that all five governing member health systems will serve as design and development partners for Longitude Cell and Gene Therapy (Longitude CGT). - The five systems—Michigan Medicine, Novant Health, Baylor Scott & White Health, Memorial Hermann Health System, and Providence—will contribute clinical, operational, financial, and technical expertise. - Longitude CGT aims to reduce administrative burden and improve patient access by addressing the operational, financial, and reimbursement complexity of cell and gene therapy delivery. - The initiative seeks to build a scalable, replicable model enabling delivery of advanced therapies beyond tertiary care centers.